Following women with endometriosis over time to see how treatments work
Follows women with endometriosis to see how treatments affect symptoms and fertility.
Plain-language title generated from the registry record
Registry title: Cohort of the Franco-European Multidisciplinary Institute of Endometriosis
Key facts
- Where
- Bordeaux, FranceSee the site
Where in France
- Clinique Tivoli-DucosBordeaux, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Clinique Tivoli Ducos
- Trial code
- NCT07243587
- Record updated
- 24 November 2025
- Original description
Endometriosis is a chronic benign gynecological condition affecting 5 to 10% of women of reproductive age, often responsible for pelvic pain, digestive symptoms, and infertility, leading to a significant reduction in quality of life. Despite its high prevalence, the long-term outcomes of different medical and surgical treatments remain poorly documented.Read full original descriptionShow less
Cohort of the Franco-European Multidisciplinary Institute of Endometriosis
Endometriosis is a chronic benign gynecological condition affecting 5 to 10% of women of reproductive age, often responsible for pelvic pain, digestive symptoms, and infertility, leading to a significant reduction in quality of life. Despite its high prevalence, the long-term outcomes of different medical and surgical treatments remain poorly documented.
The IFEMENDO study is a prospective, observational, single-center, non-interventional cohort conducted at the Endometriosis Center of Clinique Tivoli-Ducos in Bordeaux, France. The objective is to evaluate the long-term efficacy of various therapeutic strategies-both medical and surgical-in terms of symptom improvement, quality of life, recurrence, and fertility outcomes.
Women with histologically or radiologically confirmed pelvic endometriosis are invited to participate. Data are collected through standardized questionnaires at baseline and at 1, 3, 5, 7, and 10 years after inclusion, either via the secure NO ENDO online platform or in paper form. The study will contribute to a better understanding of the natural history of endometriosis and the long-term effectiveness of different treatment approaches, ultimately supporting improvements in clinical management and patient care.
Inclusion: Women aged >18 years; Women with histologically or radiologically confirmed deep endometriosis (and/or) infiltrating the colon and/or rectum; Women affiliated with the social security system.
Exclusion: Refusal to participate; Patients under guardianship or curatorship, or deprived of liberty.